Open AccessLiver Cancer–Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma
Author(s) -
Felix Lu,
Pir Ahmad Shah,
Abhishek Rao,
Cynthia Gifford-Hollingsworth,
Anne Chen,
Gary Trey,
Mina Soryal,
Arslan Talat,
Aysha Aslam,
Bilal Nasir,
Saad Choudhry,
Rizwan Ishtiaq,
Hanna K. Sanoff,
Lanla Conteh,
Anne M. Noonan,
KeQin Hu,
Carl Schmidt,
Min Fu,
Jesse Civan,
Gary Xiao,
Daryl Lau,
Xin Lü
Publication year - 2020
Publication title -
clinical and translational gastroenterology
Language(s) - English
Resource type - Journals
ISSN - 2155-384X
DOI - 10.14309/ctg.0000000000000271
Subject(s) - medicine , hepatocellular carcinoma , cirrhosis , gastroenterology , biomarker , liver cancer , hepatitis c virus , cancer , prospective cohort study , stage (stratigraphy) , hepatitis b virus , area under the curve , hepatitis c , oncology , virus , immunology , paleontology , biochemistry , biology , chemistry